HUE039037T2 - Gyógyászati dózisformák - Google Patents

Gyógyászati dózisformák

Info

Publication number
HUE039037T2
HUE039037T2 HUE15738484A HUE15738484A HUE039037T2 HU E039037 T2 HUE039037 T2 HU E039037T2 HU E15738484 A HUE15738484 A HU E15738484A HU E15738484 A HUE15738484 A HU E15738484A HU E039037 T2 HUE039037 T2 HU E039037T2
Authority
HU
Hungary
Prior art keywords
dosage forms
pharmaceutical dosage
pharmaceutical
forms
dosage
Prior art date
Application number
HUE15738484A
Other languages
English (en)
Inventor
Stefania Beato
Peggy Quinton
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HUE039037T2 publication Critical patent/HUE039037T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/45Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036Silicones; Polysiloxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HUE15738484A 2014-07-07 2015-07-06 Gyógyászati dózisformák HUE039037T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462021271P 2014-07-07 2014-07-07

Publications (1)

Publication Number Publication Date
HUE039037T2 true HUE039037T2 (hu) 2018-12-28

Family

ID=53610933

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15738484A HUE039037T2 (hu) 2014-07-07 2015-07-06 Gyógyászati dózisformák

Country Status (29)

Country Link
US (2) US10143680B2 (hu)
EP (2) EP3166596B1 (hu)
JP (2) JP6731136B2 (hu)
KR (1) KR102468610B1 (hu)
CN (1) CN106470704B (hu)
AR (1) AR101116A1 (hu)
AU (1) AU2015287336B2 (hu)
BR (1) BR112016030243B1 (hu)
CA (1) CA2954393C (hu)
CL (1) CL2017000026A1 (hu)
CY (1) CY1120749T1 (hu)
DK (1) DK3166596T3 (hu)
EA (2) EA201991359A1 (hu)
EC (1) ECSP17008187A (hu)
ES (1) ES2686704T3 (hu)
HR (1) HRP20181406T1 (hu)
HU (1) HUE039037T2 (hu)
IL (1) IL249374B (hu)
LT (1) LT3166596T (hu)
MX (1) MX2016017315A (hu)
PE (1) PE20170201A1 (hu)
PH (1) PH12016502540A1 (hu)
PL (1) PL3166596T3 (hu)
PT (1) PT3166596T (hu)
SG (1) SG11201610227TA (hu)
SI (1) SI3166596T1 (hu)
TN (1) TN2016000557A1 (hu)
TW (1) TWI707682B (hu)
WO (1) WO2016005880A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11992479B2 (en) 2018-05-03 2024-05-28 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070191487A1 (en) 2004-03-17 2007-08-16 Rigassi-Dietrich Petra G Galenic formulations of organic compounds
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
CL2008000727A1 (es) * 2007-03-13 2008-10-17 Takeda Pharmaceutical Granulo compuesto por 2-[[6-[(3r)-3-amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-4-fluorobenzonitrilo o una de sus sales y un aditivo que no comprende celulosa microcristalina; preparacion solida; comprimido y procedimi
MX2012008212A (es) * 2010-01-14 2012-08-03 Novartis Ag Uso de un agente modificador de hormonas suprarrenales.
AU2011293135A1 (en) * 2010-08-27 2013-04-11 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
AU2012304693B2 (en) * 2011-09-08 2016-03-31 Mereo Biopharma 2 Limited Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases
SI2804863T1 (sl) * 2012-01-17 2016-05-31 Novartis Ag Nove oblike in soli zaviralca sinteze ali aromataze dihidropropirolo(1,2-c)imidazolil aldosterona
WO2013126326A1 (en) 2012-02-21 2013-08-29 Celgene Corporation Solid forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, compositions and methods of use thereof
CA2869442C (en) * 2012-04-12 2020-09-08 Novartis Ag Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern

Also Published As

Publication number Publication date
EP3412278A1 (en) 2018-12-12
EP3166596B1 (en) 2018-06-06
KR102468610B1 (ko) 2022-11-21
HRP20181406T1 (hr) 2018-10-19
AU2015287336B2 (en) 2018-06-14
PL3166596T3 (pl) 2018-11-30
IL249374A0 (en) 2017-02-28
LT3166596T (lt) 2018-09-25
IL249374B (en) 2021-09-30
EP3166596A1 (en) 2017-05-17
BR112016030243A2 (pt) 2017-08-22
JP6731136B2 (ja) 2020-07-29
EA201991359A1 (ru) 2020-03-13
TWI707682B (zh) 2020-10-21
SI3166596T1 (sl) 2018-10-30
KR20170029491A (ko) 2017-03-15
CA2954393C (en) 2022-07-19
JP2019194221A (ja) 2019-11-07
TW201613586A (en) 2016-04-16
US10709691B2 (en) 2020-07-14
CN106470704A (zh) 2017-03-01
US20170202808A1 (en) 2017-07-20
MX2016017315A (es) 2017-04-27
CA2954393A1 (en) 2016-01-14
WO2016005880A1 (en) 2016-01-14
PE20170201A1 (es) 2017-04-08
CY1120749T1 (el) 2019-12-11
PH12016502540A1 (en) 2017-04-10
ES2686704T3 (es) 2018-10-19
TN2016000557A1 (en) 2018-04-04
JP2017520590A (ja) 2017-07-27
PT3166596T (pt) 2018-10-19
EA033685B1 (ru) 2019-11-15
AR101116A1 (es) 2016-11-23
CL2017000026A1 (es) 2017-07-28
US10143680B2 (en) 2018-12-04
AU2015287336A1 (en) 2017-01-12
BR112016030243B1 (pt) 2023-04-11
CN106470704B (zh) 2020-07-31
ECSP17008187A (es) 2018-03-31
DK3166596T3 (en) 2018-09-10
US20190060283A1 (en) 2019-02-28
EA201790140A1 (ru) 2017-05-31
SG11201610227TA (en) 2017-01-27

Similar Documents

Publication Publication Date Title
IL270954A (en) Pharmaceutical compounds
GB201404922D0 (en) Pharmaceutical compounds
SG11201702298VA (en) Pharmaceutical preparation
GB201416513D0 (en) Pharmaceutical compounds
GB201417707D0 (en) Pharmaceutical compounds
IL250160A0 (en) medicinal substance
SI3236952T1 (sl) Farmacevtski sestavek v obliki tablet
HRP20181406T1 (hr) Farmaceutski dozni oblici
GB201406115D0 (en) New pharmaceutical use
GB201517133D0 (en) New pharmaceutical use
GB201409662D0 (en) New pharmaceutical use
GB201508022D0 (en) Pharmaceutical compounds
GB201517454D0 (en) New pharmaceutical use
GB201517132D0 (en) New pharmaceutical use
GB201508611D0 (en) New pharmaceutical use
GB201508613D0 (en) New pharmaceutical use
GB201507813D0 (en) New pharmaceutical use
GB201416968D0 (en) Pharmaceutical compounds
GB201416969D0 (en) Pharmaceutical compounds
GB201416625D0 (en) Pharmaceutical compounds
GB201416622D0 (en) Pharmaceutical compounds
GB201416627D0 (en) Pharmaceutical compounds
GB201404896D0 (en) Pharmaceutical compounds
GB201402278D0 (en) Pharmaceutical compounds
GB201402013D0 (en) Pharmaceutical compounds